The Long Shadow of Avandia

Why is FDA so excited about the Reagan-Udall Foundation? Why is a key legislator so concerned? If both had to answer with a single word, it would be Avandia. The safety questions surrounding GSK's former blockbuster anti-diabetic go a long way towards explaining both the potential for and the political backlash against the foundation.

More from Archive

More from Pink Sheet